87 related articles for article (PubMed ID: 311800)
1. Studies on the mechanism of ristocetin-induced platelet agglutination: binding of ristocetin to platelets.
Jenkins CS; Clemetson KJ; Lüscher EF
J Lab Clin Med; 1979 Feb; 93(2):220-31. PubMed ID: 311800
[TBL] [Abstract][Full Text] [Related]
2. The effects of ristocetin and von Willebrand factor on platelet electrophoretic mobility.
Coller BS
J Clin Invest; 1978 May; 61(5):1168-75. PubMed ID: 307006
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of ristocetin-induced platelet agglutination by vancomycin.
Moake JL; Cimo PL; Peterson DM; Roper P; Natelson EA
Blood; 1977 Sep; 50(3):397-406. PubMed ID: 301760
[TBL] [Abstract][Full Text] [Related]
4. Interactions of purified rat factor VIII/von Willebrand factor with rat and human platelets--effect of albumin and ristocetin.
Dejana E; Furlan M; Barbieri B; Donati MB; Beck EA
Thromb Haemost; 1984 Aug; 52(1):57-9. PubMed ID: 6437011
[TBL] [Abstract][Full Text] [Related]
5. Platelet membrane glycoproteins implicated in ristocetin-induced aggregation. Studies of the proteins on platelets from patients with Bernard-Soulier syndrome and von Willebrand's disease.
Jenkins CS; Phillips DR; Clemetson KJ; Meyer D; Larrieu MJ; Lüscher EF
J Clin Invest; 1976 Jan; 57(1):112-24. PubMed ID: 1081991
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of von Willebrand factor-induced platelet agglutination by ADP does not result from reduced binding of total von Willebrand factor or its larger multimers.
Zucker MB; Puszkin EG; Sussman II; Mauss EA
J Lab Clin Med; 1990 Sep; 116(3):305-14. PubMed ID: 2401846
[TBL] [Abstract][Full Text] [Related]
7. Neutralization of the local negative charge carried by glycoprotein (GP)-Ib in ristocetin-induced platelet agglutination.
Tanoue K; Jung SM; Yamamoto N; Yamazaki H
Thromb Haemost; 1984 Feb; 51(1):79-83. PubMed ID: 6232731
[TBL] [Abstract][Full Text] [Related]
8. Platelet-bound ristocetin aggregation factor in normal subjects and patients with von Willebrand's disease.
Green D; Potter EV
J Lab Clin Med; 1976 Jun; 87(6):976-86. PubMed ID: 778313
[TBL] [Abstract][Full Text] [Related]
9. [Binding of factor VIII/Willebrand to Bernard-Soulier and thrombasthenic platelets (author's transl)].
Ruan C; Tobelem G; Caen JP
Nouv Rev Fr Hematol (1978); 1981; 23(2):89-93. PubMed ID: 6794004
[TBL] [Abstract][Full Text] [Related]
10. Time course of changes in in vitro platelet function and plasma von willebrand factor activity (VIIIR:WF) and factor VIII-related antigen (VIIIR:Ag) in the diabetic rat.
Winocour PD; Lopes-Virella M; Laimins M; Colwell JA
J Lab Clin Med; 1983 Nov; 102(5):795-804. PubMed ID: 6415193
[TBL] [Abstract][Full Text] [Related]
11. Agglutination of formalin-fixed, platelet-type von Willebrand's disease platelets by human von Willebrand factor.
Takahashi H; Shibata A
Thromb Haemost; 1984 Dec; 52(3):267-70. PubMed ID: 6241752
[TBL] [Abstract][Full Text] [Related]
12. Interaction of platelets, von Willebrand factor, and ristocetin during platelet agglutination.
Moake JL; Olson JD; Troll JH; Weinger RS; Peterson DM; Cimo PL
J Lab Clin Med; 1980 Jul; 96(1):168-84. PubMed ID: 6967100
[TBL] [Abstract][Full Text] [Related]
13. Studies on the mechanism of ristocetin-induced platelet agglutination. Effects of structural modification of ristocetin and vancomycin.
Coller BS; Gralnick HR
J Clin Invest; 1977 Aug; 60(2):302-12. PubMed ID: 17620
[TBL] [Abstract][Full Text] [Related]
14. Studies on the mechanism of ristocetin-induced platelet aggregation: binding of factor VIII to platelets.
Schneider-Trip MD; Jenkins CS; Kahlé LH; Sturk A; ten Cate JW
Br J Haematol; 1979 Sep; 43(1):99-112. PubMed ID: 508625
[TBL] [Abstract][Full Text] [Related]
15. Effect of insulin treatment in streptozocin-induced diabetic rats on in vitro platelet function and plasma von Willebrand factor activity and factor VIII-related antigen.
Winocour PD; Lopes-Virella M; Laimins M; Colwell JA
J Lab Clin Med; 1985 Sep; 106(3):319-25. PubMed ID: 3928783
[TBL] [Abstract][Full Text] [Related]
16. Defective ristocetin-induced platelet aggregation in von Willebrand's disease and its correction by factor VIII.
Weiss HJ; Rogers J; Brand H
J Clin Invest; 1973 Nov; 52(11):2697-707. PubMed ID: 4201262
[TBL] [Abstract][Full Text] [Related]
17. Agglutination of platelet-type von Willebrand's disease platelets by bovine von Willebrand factor.
Takahashi H; Shibata A
Thromb Haemost; 1985 Apr; 53(2):204-7. PubMed ID: 2992113
[TBL] [Abstract][Full Text] [Related]
18. Ristocetin and botrocetin involve two distinct domains of von Willebrand factor for binding to platelet membrane glycoprotein Ib.
Girma JP; Takahashi Y; Yoshioka A; Diaz J; Meyer D
Thromb Haemost; 1990 Oct; 64(2):326-32. PubMed ID: 1702906
[TBL] [Abstract][Full Text] [Related]
19. Role of platelet membrane glycoproteins Ib/IX and IIb/IIIa, and of platelet alpha-granule proteins in platelet aggregation induced by human osteosarcoma cells.
Clezardin P; Drouin J; Morel-Kopp MC; Hanss M; Kehrel B; Serre CM; Kaplan C; Delmas PD
Cancer Res; 1993 Oct; 53(19):4695-700. PubMed ID: 7691402
[TBL] [Abstract][Full Text] [Related]
20. Von Willebrand's disease with spontaneous platelet aggregation induced by an abnormal plasma von Willebrand factor.
Grainick HR; Williams SB; McKeown LP; Rick ME; Maisonneuve P; Jenneau C; Sultan Y
J Clin Invest; 1985 Oct; 76(4):1522-9. PubMed ID: 2932469
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]